Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
9.76
-0.38 (-3.75%)
At close: Sep 16, 2025, 4:00 PM EDT
9.57
-0.19 (-1.95%)
After-hours: Sep 16, 2025, 5:33 PM EDT

Avalo Therapeutics Market Cap

Avalo Therapeutics has a market cap or net worth of $128.37 million as of September 16, 2025. Its market cap has increased by 1,265.61% in one year.

Market Cap
128.37M
Enterprise Value
15.78M
1-Year Change
1,265.61%
Ranking
Category
Stock Price
$9.76

Market Cap Chart

Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $128.37M, an increase of 272.08%. That is a compound annual growth rate of 14.27%.

History

DateMarket Cap% Change
Sep 16, 2025128.40M66.32%
Dec 31, 202477.20M957.53%
Dec 29, 20237.30M-84.60%
Dec 30, 202247.40M-75.17%
Dec 31, 2021190.90M-3.49%
Dec 31, 2020197.80M-16.79%
Dec 31, 2019237.70M80.35%
Dec 31, 2018131.80M58.03%
Dec 29, 201783.40M917.07%
Dec 30, 20168.20M-71.63%
Dec 31, 201528.90M-16.23%
Nov 13, 201534.50M-
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition